Ibotta CEO Bryan Leach thinks it's a "huge mistake" to try to time the IPO market because the IPO process is long.
The IPO market has become red hot — at least among venture capital–backed biopharma and other life sciences companies. In the ...
BC Partners-backed Springer Nature is targeting a valuation of as much as €4.7bn in a delayed flotation in Frankfurt in ...
Drinks maker China Resources Beverage is aiming to launch its Hong Kong initial public offering to raise up to $1 billion in ...
WOL 3D India IPO opened for subscription on September 23, aiming to raise ₹25.56 crore. The issue was fully subscribed within ...
Moove Lubricants Holdings (MOOV) has filed to raise $100 million in an IPO of its common stock, according to an SEC F-1 ...
Zabka, the Polish convenience store operator, is seeking to list on the Warsaw Stock Exchange in the country's first IPO ...
The company has announced a price range of ₹159 to ₹168 per share for its public offering, which amounts to ₹158 crore.